BioAffinity Technologies (BIAF) said Thursday it closed a public offering of 4 million common shares and pre-funded warrants at $0.80 apiece for gross proceeds of $3.2 million.
Each pre-funded warrant is exercisable for one common share and is immediately exercisable, according to a statement.
Price: $0.85, Change: $+0.01, Percent Change: +1.62%